In2Bones gains FDA clearance for total ankle system

In2Bones on Feb. 6 received FDA approval for its Quantum total ankle system.

Advertisement

Four insights:

1. Quantum is intended for patients suffering from arthritis.

2. The total ankle system aims to improve patient mobility and stability and facilitate implant placement.

3. Quantum features a cruciate-shaped vertical stem in the tibia to enhance stability and fixation.

4. In2Bones will begin a controlled market release in the summer. Full market launch is set for the first quarter of 2021.

More articles on devices:
How will total disc replacement develop in spine? 9 spine surgeons share insights
DMC loses appeal to keep neurosurgical residency: 4 details
Neurologist found guilty in $150M fraud scheme alongside 3 other physicians

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.